About us
SOMAPHARM supplies innovative medical products for surgical departments and emergency medicine.
Based on our more than 30 years of experience, SOMAPHARM plans to become one of the leading providers of innovative medical technology within the next three to five years with new management and new investments.
To this end, an Europe-wide expansion is planned with new, groundbreaking technologies in the fields of Surgery and Intensive Care Healthcare.
Our products shall be launched on the global stage after clinical studies and the corresponding approvals.
Management
Rajko Babovic
Chief Executive Officer SOMAPHARM AG
Mr. Babovic is the new wind at SOMAPHARM
After creating the new business and development plan for the company, it is his job to attract new investments and maintain investor relationships, while keeping a disciplined eye on a healthy P&L statement of SOMAPHARM’s day-to-day operations in Switzerland.
With his many years of experience as a “serial entrepreneur”, Mr Babovic coordinates the interface between the product innovation department and the profitable product sales and maintenance team in Baar, thus ensuring a steady income thanks to which his new innovation strategy can unfold its full potential for SOMAPHARM’s investors.
Mr Babovic’s particular focus is on his personal oversight of the business development of SOMAPHARM’s new, innovative medical technology products, in collaboration with leading partners from around the world, as a key strategic factor in driving the company’s new value in the Swiss market.
History
Foundation of SOMAPHARM AG.
Import of Viagra into Switzerland
Takeover of the company by the Weisser brothers
Expansion to include the SOMA Hospital Care division, with disposable and reusable medical products as well as medical technology devices for professional areas of application in hospitals, clinics, medical practices and research.
Expansion of the SOMA Digi-Data division with professional IT support for hospitals, clinics and medical practices.
Expansion of quality management according to the ISO 13485: 2003 standard and CE certification.
Expansion of the SOMA Beauty division with innovative products in the field of cosmetics.
Expansion and distribution of a hand-held high pressure syringe (NOMA-I) for angioplasty.
Development of your own innovation – NOMA I
Development and sales of a single-use hand drill NOMA-II for skull trepanation.
Development and sale of a catheter for measuring the length of the urethra in incontinence operations
Studies with Woundclot / USZ / Dr. Bredell tooth and mouth surgery. Hemodialysis videos / pictures in the following clinics: Aarau, Liestal, Chur
Start of cooperation with Cardisio to develop the first high-precision and non-invasive test to determine a risk factor for coronary heart disease
Contract negotiation and production of Alise in the USA – the new portable miniaturized heart-lung machine
Concentration on fast and efficient Covid19 fight in Switzerland – products sourced in China and sold in Europe
Generation change at SOMA + PHARM – New management and new business plan, based on SOMA + PHARM’s own innovations and innovations from partners worldwide
Created with Sketch.
Created with Sketch.
Created with Sketch.
Created with Sketch.
Created with Sketch.
Created with Sketch.
Created with Sketch.
Created with Sketch.
Created with Sketch.
Created with Sketch.
Created with Sketch.
Created with Sketch.
Created with Sketch.
Created with Sketch.
Created with Sketch.
Created with Sketch.
1989
1998
2003
2007
2009
2009
2010
2012
2013
2014
2016
2017
2018
2019
2020
2021
You have questions about SOMAPHARM AG and would like to learn more about our products?
Philosophy
Innovation
We are active on the market with new products and product ideas to assist users in clinics, practices and research to effectively and optimally care for their patients.
Reliability
We use all of our resources to meet the demands and needs of our customers. We use all our resources to meet our customers’ needs and requirements. Reliability towards you is our highest priority.
Transparency
Our price structure is adapted to the healthcare market’s current financing practices. We value the greatest possible openness and transparency in our business relationships. Our own nationwide distribution network makes us the ideal partner for the healthcare sector.
Changes in today’s market are our motivation and the individual needs of our customers are our challenge.
Continuity
The rapid changes in today’s market are a major challenge for our performance. We therefore rely on our highly motivated employees, who have a high level of specialist and advisory skills through constant training and further education.
Are you interested in further studies by Somapharm AG?
Informationen about SOMAPHARM AG?